TTNP($2.01) - Data analysis delayed Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine http://finance.yahoo.com/news/Titan-Pharmaceuticals-iw-1047680571.html?x=0&.v=1